Philip Morris International Inc. (TSX:ZYNS)
Canada · Delayed Price · Currency is CAD | Market Cap | 413.10B +8.2% |
| Revenue (ttm) | 57.92B +8.1% |
| Net Income | 15.45B +46.0% |
| EPS | 9.91 +46.1% |
| Shares Out | n/a |
| PE Ratio | 26.75 |
| Forward PE | 22.02 |
| Dividend | 0.61 (2.33%) |
| Ex-Dividend Date | Jun 25, 2026 |
| Volume | 800 |
| Open | 26.36 |
| Previous Close | n/a |
| Day's Range | 25.88 - 26.36 |
| 52-Week Range | 19.95 - 26.54 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jul 22, 2026 |
About TSX:ZYNS
Philip Morris International Inc. operates as a tobacco company. The company offers cigarettes and smoke-free products, including heat-not-burn, e-vapor, and oral nicotine products under the IQOS, VEEV, and ZYN brands; and consumer accessories, such as lighters and matches. It also offers wellness products. The company was incorporated in 1987 and is headquartered in Stamford, Connecticut. [Read more]
Financial Performance
In 2025, TSX:ZYNS's revenue was $40.65 billion, an increase of 7.31% compared to the previous year's $37.88 billion. Earnings were $11.32 billion, an increase of 60.88%.
Financial numbers in USD Financial StatementsNews
Philip Morris International Earnings release: Q2 2026
Philip Morris International released its Q2 2026 earnings on July 22, 2026, summarizing the period's financial results.
Philip Morris Sales Boosted by Growth in International Business
Philip Morris International recorded higher revenue in the second quarter, boosted by growth in its international business and its Zyn portfolio in the U.S.
Philip Morris beats second-quarter sales estimates
Philip Morris beat Wall Street estimates for second-quarter sales on Wednesday, helped by strong demand for smoke-free products following recent regulatory approval for its Zyn nicotine pouche...
Philip Morris International Reports 2026 Second-Quarter & First Six-Months Results and Updates 2026 Full-Year Adjusted Diluted EPS Forecast for Currency Only;
STAMFORD, CT--(BUSINESS WIRE)--Regulatory News: Philip Morris International Inc. (PMI) (NYSE: PM) today announces its 2026 second quarter results.1 "We delivered outstanding results in the second quar...
Philip Morris initiated with a Buy at BTIG
BTIG initiated coverage of Philip Morris (PM) with a Buy rating and $216 price target The company has executed its transition to reduced-risk products exceptionally well, maintaining a resilient combu...
Philip Morris International to Host Webcast of 2026 Second-Quarter and First Six-Months Results
STAMFORD, CT--(BUSINESS WIRE)--Regulatory News: Philip Morris International Inc. (PMI) (NYSE: PM) will host a live audio webcast on Wednesday, July 22, 2026, at 9:00 a.m. ET, to discuss its 2026 secon...
Investors flock to Big Tobacco as companies pivot to vapes and pouches — as moral taboo goes up in smoke
For nearly a decade, pension funds and major endowments blacklisted cigarette makers under strict sustainability mandates.
Tobacco Stocks Are Coming in From the Cold
Investors are taking a closer look at companies as they shift away from cigarettes.
Philip Morris price target raised to $182 from $168 at UBS
UBS raised the firm’s price target on Philip Morris (PM) to $182 from $168 and keeps a Neutral rating on the shares.
Wall Street Reiterates Bullish Philip Morris (PM) Stock Ratings on Updated FDA Tobacco Risk Warnings
Philip Morris stock earned bullish analyst ratings on Wednesday following a tobacco risk update from the FDA.
Zyn can be marketed as safe alternative to cigarettes, FDA says
Federal regulator gives Philip Morris International a win for nicotine pouches.
FDA lets Philip Morris market Zyn nicotine pouches as less harmful than cigarettes
The FDA will allow 20 Philip Morris-owned Zyn nicotine pouch products to carry a modified-risk claim saying switching from cigarettes lowers the risk of several smoking-related diseases. The decision ...
Philip Morris gets FDA Modified Risk Tobacco Product orders for 20 ZYN products
Philip Morris (PM) International announced that the U.S. Food and Drug Administration issued Modified Risk Tobacco Product orders for 20 variants of ZYN nicotine pouch products. “These are the first…
FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products
STAMFORD, CT--(BUSINESS WIRE)--Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for...
FDA allows Philip Morris to market Zyn as less harmful than cigarettes
The U.S. Food and Drug Administration said on Tuesday it would allow Philip Morris to market its Zyn nicotine pouches as less harmful than cigarettes.
US FDA proposes rule to tighten oversight of foreign tobacco makers
The U.S. Food and Drug Administration proposed a rule on Friday that would require foreign tobacco product makers to register their facilities and list products sold in the country.
The WSJ Leadership Institute Names Philip Morris International Among “Best Companies For the Future”
STAMFORD, CT--(BUSINESS WIRE)--Philip Morris International Inc. (PMI) (NYSE: PM) has been named in the WSJ Leadership Institute's inaugural “Best Companies for the Future” ranking, which evaluates lar...
Philip Morris International Declares Regular Quarterly Dividend of $1.47 Per Share
STAMFORD, CT--(BUSINESS WIRE)--Regulatory News: The Board of Directors of Philip Morris International Inc. (NYSE: PM) today declared a regular quarterly dividend of $1.47 per common share, payable on ...
Italy Slaps Philip Morris with €7M Fine for Misleading ‘Smoke-Free’ Marketing Claims
Italy’s competition authority, AGCM, has fined Philip Morris’ ($PM) Italian unit €7 million ($8.1 million) for allegedly misleading marketing of non-combustion tobacco offerings. The company said that...
Italy fines Philip Morris €7 million over 'smoke-free' marketing claims
Italy's competition authority on Wednesday slapped a €7 million ($8.1 million) fine on Philip Morris' Italian unit over allegedly misleading marketing for non-combustion tobacco products.
Philip Morris price target raised to $200 from $190 at Morgan Stanley
Morgan Stanley raised the firm’s price target on Philip Morris (PM) to $200 from $190 and keeps an Overweight rating on the shares. Philip Morris’ announcement at an investor conference…
Counterfeit Cigarettes Drive EU Illicit Market Above 10% for First Time Since 2014
STAMFORD, CT--(BUSINESS WIRE)--A new study detailing the scale of the illicit cigarette trade in the European Union (EU) shows that consumption of black-market cigarettes rose more than 7% year-on-yea...
Philip Morris cuts annual profit forecast on cost pressure, weak pricing power
Philip Morris cut its annual profit forecast on Tuesday, with CEO Jacek Olczak citing margin pressure due to higher energy costs from the Iran conflict and currency swings, at a time when consumers ...
Philip Morris to Post $500 Million Impairment on Canada Affiliate
Philip Morris International said it is booking a roughly $500 million impairment charge in the second quarter to reduce the carrying value of its investment in Canadian affiliate Rothmans Benson & Hed...
Philip Morris cuts FY26 adjusted EPS view to $8.31-$8.46 from $8.36-$8.51
Consensus $8.41. Philip Morris (PM)’ Group CEO PMI, Jacek Olczak, will address investors at the 2026 dbAccess Global Consumer Conference in Paris. The company said, “PMI updates its 2026 full-year…